Our studies have shown that tumoral CD147 increased the production by endothelial cells of VEGF soluble isoforms (particularly the most angiogenic isoforms) and of its main receptor VEGFR-2 through the transcription factor HIF-2α, both in vitro and in experimental tumor models in vivo. Here, KDR is linked to neoplasm.